UnitedHealth Group Stock Trades Below 52-Week High Ahead of Q3 Results
UnitedHealth Group (ISIN US91324P1021) was trading at EUR 331.50 on October 5, 2026, at 9:08 a.m. CEST, which is 28.19 percent below its 52-week high of EUR 461.62. The company announced on September 15, 2026, that it will release its third-quarter 2026 results on October 13, before the market opens.
The latest operating results show significant improvement compared to the same period last year. In the second quarter of 2026, adjusted earnings per share reached USD 6.38, up from USD 4.08 in the second quarter of 2025. Revenue totaled USD 112.00 billion, according to Fortune on July 16, 2026. The medical care ratio also improved to 86.70 percent from 89.40 percent in the year-earlier quarter, while operating earnings reached USD 8.00 billion and grew 55.00 percent year over year.
Management raised its fiscal 2026 adjusted earnings per share guidance to USD 19.50-20.00 and increased planned 2026 share repurchases to at least USD 5.00 billion from an initial USD 2.50 billion, as reported in the July 16 earnings call by Fortune. As of September 18, 2026, MarketBeat reported a Moderate Buy consensus from 27 research firms, including 19 Buy ratings, seven Holds, and one Strong Buy. The average 12-month price target was USD 456.56.
At EUR 331.50, the Lang & Schwarz quote stood EUR 1.10 above the prior close of EUR 330.40, equal to plus 0.33 percent. The primary listing is on the NYSE, where the finance quote showed USD 371.90 on October 2, 2026, with a market capitalization of USD 337.7 billion and a 52-week range of USD 255.97 to USD 461.62.